Case-control study finds systemic hypertension is an independent risk factor for polypoidal choroidal vasculopathy, indicating a link between vascular disease and choroidal damage.
PURPOSE: To determine the association between hypertension and polypoidal choroidal vasculopathy (PCV), and to identify demographic subgroups with enhanced susceptibility. METHODS: This retrospective case-control study enrolled 101 patients with PCV and 101 age-matched controls without retinal disease. The primary outcome was the odds ratio (OR) for PCV comparing both groups. Secondary analyses examined age- and gender-stratified associations. Logistic regression adjusted for age and gender. RESULTS: Hypertension was significantly more prevalent in PCV cases (84.2%, 85/101) compared to controls (60.4%, 61/101), with an unadjusted OR of 3.48 (95% CI: 1.79-6.78; P<0.001). The association was particularly strong in patients older than 70 years (OR=7.14, P=0.001) and in males (OR=3.34, P=0.002). After adjustment for age and gender, hypertension remained an independent risk factor for PCV (adjusted OR=3.43, 95% CI: 1.72-6.82; P<0.001). Multicollinearity was absent (all Variance Inflation Factor [VIF]<3). CONCLUSION: Hypertension is a significant independent risk factor for PCV, with increased risk in elderly and male patients. These findings suggest a mechanistic link between systemic hypertensive vascular disease and choroidal vasculopathy development and may inform clinical screening and risk stratification in hypertensive populations.
No takes yet. Share an insight, caveat, or question.
Biswas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: